This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hur, J. Articles by Shioda, T. Search for Related Content PubMed PubMed Citation Articles by Hur, J. Articles by Shioda, T.

Regulation of Expression of BIK Proapoptotic Protein in Human Breast Cancer Cells: p53-Dependent Induction of BIK mRNA by Fulvestrant and Proteasomal Degradation of BIK Protein

¹ Department of Tumor Biology, ² Molecular Profiling Laboratory, and ³ Center for Cancer Risk Analysis, Massachusetts General Hospital Center for Cancer Research, Charlestown, Massachusetts

Requests for reprints: Toshi Shioda, Massachusetts General Hospital Center for Cancer Research, Building 149, 7th Floor, 13th Street, Charlestown, MA 02129. Phone: 617-726-3425; Fax: 617-726-5637; E-mail: tshioda{at}partners.org.

Induction of mRNA for BIK proapoptotic protein by doxorubicin or -irradiation requires the DNA-binding transcription factor activity of p53. In MCF7 cells, pure antiestrogen fulvestrant also induces BIK mRNA and apoptosis. Here, we provide evidence that, in contrast to doxorubicin or -irradiation, fulvestrant induction of BIK mRNA is not a direct effect of the transcriptional activity of p53, although p53 is necessary for this induction. It is known that p53 up-regulated modulator of apoptosis (PUMA) mRNA is induced directly by the transcriptional activity of p53. Whereas -irradiation induced both BIK and PUMA mRNA, only BIK mRNA was induced by fulvestrant. Whereas both fulvestrant and doxorubicin induced BIK mRNA, only doxorubicin enhanced the DNA-binding activity of p53 and induced PUMA mRNA. Small interfering RNA (siRNA) suppression of p53 expression as well as overexpression of dominant-negative p53 effectively inhibited the fulvestrant induction of BIK mRNA, protein, and apoptosis. Transcriptional activity of a 2-kb BIK promoter, which contained an incomplete p53-binding sequence, was not affected by fulvestrant when tested by reporter assay. Fulvestrant neither affected the stability of the BIK mRNA transcripts. Interestingly, other human breast cancer cells, such as ZR75-1, constitutively expressed BIK mRNA even without fulvestrant. In these cells, however, BIK protein seemed to be rapidly degraded by proteasome, and siRNA suppression of BIK in ZR75-1 cells inhibited apoptosis induced by MG132 proteasome inhibitor. These results suggest that expression of BIK in human breast cancer cells is regulated at the mRNA level by a mechanism involving a nontranscriptional activity of p53 and by proteasomal degradation of BIK protein. (Cancer Res 2006; 66(20): 10153-61)

This article has been cited by other articles:

				K. R. Coser, B. S. Wittner, N. F. Rosenthal, S. C. Collins, A. Melas, S. L. Smith, C. J. Mahoney, K. Shioda, K. J. Isselbacher, S. Ramaswamy, et al. Antiestrogen-resistant subclones of MCF-7 human breast cancer cells are derived from a common monoclonal drug-resistant progenitor PNAS, August 25, 2009; 106(34): 14536 - 14541. [Abstract] [Full Text] [PDF]

				D. Y. Lim and J. H. Y. Park Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin Am J Physiol Gastrointest Liver Physiol, May 1, 2009; 296(5): G1060 - G1068. [Abstract] [Full Text] [PDF]

				S. Bhattacharyya, A. Borthakur, P. K. Dudeja, and J. K. Tobacman Carrageenan Induces Cell Cycle Arrest in Human Intestinal Epithelial Cells in Vitro J. Nutr., March 1, 2008; 138(3): 469 - 475. [Abstract] [Full Text] [PDF]